Latest Recipharm News & Updates

See the latest news and media coverage for Recipharm. We track all announcements, press releases, and industry mentions in real time, all in one place.

Recipharm

CDMO for pharmaceuticals and biologics

recipharm.com

Headquarters: Stockholm, Sweden
Founded year: 1995
Company type: Private company
Number of employees: 5,000–10,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Recipharm

In short: Recipharm appointed Greg Behar as CEO, invested in global manufacturing expansions, and sold its Israeli facility to Scinai.

Company announcements

June 15 Recipharm

Recipharm expands US sterile fill and finish capabilities for biologics

The multi-million-dollar investment enhances capacity for biologics and advanced therapies, following a clinical fill and finish agreement with a major pharma company.

April 16 Recipharm

Recipharm receives CEPI seed funding for Analysis Zero

The funding supports development of NMR-based real-time PAT to monitor RNA vaccine CQAs, aiming to accelerate batch release, reduce costs and improve global vaccine access.

April 15 Recipharm

Recipharm publishes 2025 sustainability report

It highlights 20% Scope 1 and 74% Scope 2 emissions reductions, 100% renewable electricity, and strong CDP scores. They partner with customers to cut Scope 3 emissions.

April 8 Recipharm

Recipharm reports strong 2025 sustainability performance

Earned B for Climate Change, A- for Water Security, A for Supplier Engagement from CDP. Cut Scope 1 emissions 20%, Scope 2 74% vs 2021.

Media coverage

August 3 Pharmaphorum

Change at the top at Recipharm as strategy shifts

Swedish contract development and manufacturing organisation (CDMO) Recipharm has appointed former Nestlé Health Sciences' chief executive Greg Behar as its new CEO, replacing Marc Funk...

July 23 Dagens PS

Major owners try to drive up EQT's bid further

Private equity firm EQT announced on Monday a bid for contract manufacturer Recipharm. The prospects for the acquisition are good and the company's founders have already rallied behind the bid. EQT...

April 15 Pharmaceutical Commerce

A Productive Day: Recipharm Completes Two Biologics Deals | Pharmaceutical Commerce

CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector...

March 24 The Globe and Mail

Scinai Immunotherapeutics Buys Recipharm Israel Unit, Seals Strategic CDMO Pact

Detailed price information for Scinai Immunotherapeutics Ltd ADR (SCNI-Q) from The Globe and Mail including charting and trades.

Never miss news about Recipharm

Track Recipharm and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Recipharm competitors & trending companies

Browse news for competitors to Recipharm and other trending companies.